Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study

Overview of attention for article published in BMC Gastroenterology, April 2016

Altmetric Badge

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 21 Mendeley

Summary Dimensions citations

So far, Dimensions has found 13 publications that cite this research output.

13

The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.

Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.

Article in American Journal of Cancer Research (February 2023)

Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy

Article in Cancers (October 2022)

Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.

Article in American Journal of Cancer Research (December 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.